[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.139.136. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 24, 1973

Medical News

JAMA. 1973;226(13):1507-1514. doi:10.1001/jama.1973.03230130001001

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Recently discovered particle may be hepatitis A virus  A small, virus-like particle, believed to be the causative agent of hepatitis A, has been visualized by investigators at the National Institute of Allergy and Infectious Diseases (NIAID).This visualization, using immune electron microscopy, should help in attempts to isolate the virus in cell culture, which in turn is a prerequisite to manufacture of a vaccine.More immediately, the discovery of this viruslike antigen—and development of a technique with which to detect antibody to it—provide a means of diagnosing and studying hepatitis A. Testing for antibody to hepatitis A antigen may prove useful in standardizing the potency of immune serum globulin, the NIAID investigators suggest.Stephen M. Feinstone, MD; Albert Z. Kapikian, MD, and Robert H. Purcell, MD, reported on the procedures they used in visualizing the spherical, 27 nm particles in the acute-phase stool filtrates of hepatitis A patients in recent (Dec 7) issue of

×